Skip to content

Sector benchmark

Where does a company stand against its sector? Every ratio over five fiscal years, with its place among its peers and what that means, ready to print for your client.

Sector benchmark

GRANDFILS SRL

BE 0716.632.733
NACE 86.220, Specialist medical practice
NACE division 86, Human health activities all sizesfiscal years 2020 to 202410,995 to 23,179 sector peers per ratio

Summary

fiscal year 2024

GRANDFILS SRL does better than half of its sector on 2 of the 8 ratios compared.

most favourable quarter above the median below the median least favourable quarter
Strongest points
  • Long-term debt ratiobetter than 55%
  • Return on equitybetter than 53%
Points to watch
  • Current ratiobetter than 35%
  • Working-capital ratiobetter than 35%
  • Debt to equitybetter than 36%

Solvency and debt

How soundly the company is financed.
Solvency
56.5%▼2024

Solvency is below 60% of 23,179 sector peers: less favourable than the median.

Position against the sector weakening since 2020.

20202021202220232024
Debt to equity
0.77▲2024

Debt to equity is above 64% of 22,836 sector peers: less favourable than the median.

Position against the sector weakening since 2020.

20202021202220232024
Long-term debt ratio
0.26▼2024

The long-term debt ratio is below 55% of 10,995 sector peers: more favourable than the median.

20202021202220232024
Interest coverage
29.18▼2024

Interest coverage is below 60% of 22,035 sector peers: less favourable than the median.

Position against the sector weakening since 2020.

20202021202220232024

Liquidity

Whether it can pay its short-term bills.
Current ratio
1.94▼2024

The current ratio is below 65% of 22,848 sector peers: less favourable than the median.

Position against the sector weakening since 2020.

20202021202220232024
Working-capital ratio
26.9%▼2024

The working-capital ratio is below 65% of 23,152 sector peers: less favourable than the median.

Position against the sector weakening since 2020.

20202021202220232024

Profitability

What the company earns on its assets and its sales.
Return on equity
31.0%▼2024

Return on equity is above 53% of 21,722 sector peers: more favourable than the median.

Position against the sector weakening since 2020.

20202021202220232024
Return on assets
17.5%▼2024

Return on assets is below 52% of 23,132 sector peers: less favourable than the median.

Position against the sector weakening since 2020.

20202021202220232024

Not computable

Net margin, EBITDA margin, Gross margin, Days sales outstanding, Days payable outstanding, Days inventory. This company files the abbreviated or micro schema, in which turnover and purchases are optional; margins and credit terms therefore cannot be taken from its figures.

Source: filed annual accounts (NBB) and main activity (CBE register). Compared per fiscal year with each peer's latest statutory accounts; at least 30 peers per ratio. Prepared on 26 September 2026 via checked.be.